— Know what they know.
Not Investment Advice
Also trades as: BITRF (OTC) · $vol 0M

BIT.AX ASX

Biotron Limited
1W: +0.0% 1M: -20.0% 3M: -33.3% YTD: -33.3% 1Y: -33.3% 3Y: -93.1% 5Y: -95.3%
A$0.00 ($0.00)
+0.00 (+0.00%)
 
ASX · Healthcare · Biotechnology · Tech Score Neutral · Power 45 · A$3.3M mcap · 1.72B float · 0.166% daily turnover

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$2K -100.1% ▼
Operating Income
-$2M -469.0% ▼
Net Income
-$2M -376.6% ▼
EPS (Diluted)
$0.00 +100.0% ▲
EBITDA
-$2M -476.9% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$2M$1M$2M$2M$0
YoY Growth+6.6%-8.2%+14.9%+10.2%-100.0%
Cost of Revenue$45K$43K$40K$0$2K
Gross Profit$2M$1M$2M$2M-$2K
Gross Margin97.1%97.0%100.0%100.0%—
R&D Expenses$3M$3M$4M$535K$683K
SG&A Expenses$1M$2M$1M$2M$1M
Operating Expenses$4M$5M$5M$2M$2M
Operating Income-$3M-$5M-$5M-$339K-$2M
Operating Margin-178.3%-352.0%-313.1%-18.7%—
Interest Expense$5K$4K$1K$15K$0
Income Before Tax-$3M-$5M-$3M-$319K-$2M
Tax Expense$5-$1M-$2M-$2M-$526K
Net Income-$3M-$3M-$3M-$319K-$2M
Net Margin-178.4%-244.0%-208.9%-17.6%—
EPS (Diluted)$-0.00$-0.00$-0.00$-0.00$0.00
EBITDA-$3M-$5M-$5M-$334K-$2M
Shares Outstanding725M821M902M999M2.07B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms